OOH Hancocks or should i say Waldo my son, that may upset a few PEB punters.
Printable View
OOH Hancocks or should i say Waldo my son, that may upset a few PEB punters.
It may also save a few skins
Hes a long time holder and supporter but has left his emotions at the door it seems [along with Sparky],which is a good thing IMHO
Market sentiment is like a boat without a rudder[no news] at this stage.
It has been all over the place as we have seen in the last few weeks.
Id be really surprised if they dont get the ok in the states---Market uptake is the holy grail
In my most humble opinion, I believe the technical indicators are based on what the SP is doing. I totally agree that knowledge and research is paramount to trading/investing with confidence. Understanding the dynamics of the candles, volumes, moving averages, RSI and chart patterns etc really helps also. For example, I believe we are nearing the end of a pennant structure with PEB and unless something totally unexpected happens, I expect the price to surge again soon. Totally agree with you Hancock's and Sparky about the fundamentals too, which gives me more confidence to expect an upsurge soon. Of course I could be all up the booeye too, but that's the market risk. Lastly, I think the market is now in the middle of pricing in the expected sales data. It has been my experience that the major money is made prior to the data becoming public. The crumbs come after the event.
Here's how the market will price PEB if the US proves to be a success :
260,000 tests x US$500 per test = US$130m
Profit margin = 60% = US$78m
Market will get excited about the other tests in the pipeline so will give PEB a multiple of 25 times = US$1950m = NZ$2.335b
279m shares on issue
So share price will be $8.37 per share.
How's that for bullishness?
Dentie is referring to the imminent announcement of the lab certification?
That is public information. Where they are at with it and how likely they are to get it - that is insider information if someone knows and use that infor before the rest of the market is informed.
So far, PEB has been on time and on schedule. With these things however, always expect delays.
Hi Hancocks (& Balance). I was not referring to insider trading - and most definitely was not referring to PEB in this way ... they appear to be a great firm.
In the context of the rest of my post, I was just trying to get the point across that if traders and/or investors got their fundamental and technical research right - and their tolerance for risk, patience and belief systems etc etc, then they are normally the early birds. Hence, by the time other traders and/or investors finally decided it was right for them to join in - the early birds would have already made a nice return. But, as we know, there is always the unknown factors (or the uncalculable) that can occur in the market and that's when the possibility for a loss exists. Potential loss and minimisation of risk etc is down to the individual.
The bottom line is...as a lot of posters ahve said ... do your homework, learn the game and trust your instincts. I would say if you are a nervous nellie, then either don't play in the market, or at least only play with what you can afford to lose.
I'm pretty sure at the AGM last year they said they were aiming for the CxBladder launch in the US during March.
The half year report to the end of September 2012 said that "Looking forward, the next six months will be focused on the US market roll-out, putting in place operating protocols, running the facility to specification and filing the respective documentation with CLIA in New York to obtain the required regulatory approval that will enable us to start our commercial offerings to urologists."
PEB's announcement on the 17th October 2012 regarding the completion of their US laboratory stated, "The purpose-built laboratory in Hershey, Pennsylvania is expected to complete regulatory approval and be fully operational in March 2013 to offer Pacific Edge's bladder cancer diagnostic test, Cxbladder, as a Laboratory Developed Test (LDT) to clinicians throughout the United States."
I haven't heard otherwise to say this isn't happening, so like others I expect it in the next wee while, even if they are running a little bit behind their estimates from last year.
I think his point was more the last 2 sentences of the paragraph.
They seem to have a good product--the job now is to promote it
Well said, DavidB.
Those investing (or even speculating in PEB) need to read your last posting very carefully.
Good returns have been made the likes of DIL but they are some of the hardest investments to make and monitor. The gyrations in their share prices as punters move in and out were worse than any roller coaster ride you could ever encounter.
Better have the stomach for it.
Settle down David ... it sounds like you have been been rough trod by some previous unsuspecting Bio firm. Given your comments, you appear to be an authority on bio firms and what their share prices are doing (or should be doing). Despite many questions from me - who is desperately trying to learn - nobody has given me any credible reason as to why the like of XRO is riding at the level it is. To me, everything tells me they are riding on thin air alone. At $8, when the likes of Ryman for example is travelling nicely - but only at $4.60.... I can't make a rationale comparison in either fundamentals or technicals. Can you help me?
Just want to +1 David B's post/rant, very refreshing.
It's painful to see dumb money invested & subsequently lost in poorly understood investments/speculations. (Not saying PEB is this.)
I just thought David B has raised some valid points in reference to PEB, that can also be applied generally to people investing in companies/industries they may not fully understand (not specifically anyone here.)
I was showing appreciation to his post/rant.
I'm not here to tread on any toes, just to learn more about different investment opportunities. :)
*Back to PEB talk*
Here's some PEB talk .....
http://www.sbwire.com/press-releases...sed-213808.htm
It looks fairly simple to me PEB is at a speculative price certainly not its base value so buying at its present share price is a real punt and hope like hell its a goer. those who purchased under 30 cents have a bit of slack if things don't go quite like is expected.